<PAGE> 1
EXHIBIT 99.3
Pursuant to Rule 13d-1(k)(1)(iii) of Regulation 13D-G of the General Rules
and Regulations of the Securities and Exchange Commission under the Securities
Exchange Act of 1934, as amended, the undersigned agrees that the one statement
relating to the common stock of Moore Medical Corp. to which this Exhibit is
attached, and any subsequent amendments thereto, is filed on behalf of each of
them in the capacities set forth below.
DATED: August 16, 2000
/s/ Christopher W. Brody
------------------------
Christopher W. Brody
VANTAGE VENTURE PARTNERS, LP
By: VANTAGE PARTNERS, LLC,
its general partner
By: /s/ Christopher W. Brody
--------------------------------
Christopher W. Brody
Chairman
